gms | German Medical Science

73. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
Joint Meeting mit der Griechischen Gesellschaft für Neurochirurgie

Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.

29.05. - 01.06.2022, Köln

ePoster Dienstag, 31.05.2022

Meeting Abstract (P128)

How the lesioned brain perceives the self- self-referential processing in glioma patients

Na CH, Jütten K, Forster S, Clusmann H, Mainz V
[Full Text]
Meeting Abstract (P129)

Therapeutic anticoagulation impacts MR morphologic recurrence patterns in glioblastoma – a matched-pair analysis

Dubinski D, Won SY, Behmanesh B, Dosch M, Puchinin V, Baumgarten P, Bernstock J, Voss M, Konczalla J, Czabanka M, Freiman TM, Geßler F
[Full Text]
Meeting Abstract (P130)

Is the distance between patient's residency and the speciality clinic a predictor for overall survival of Glioblastoma patients?

Kamp MA, Bartholdt A, Dinc N, von Sass C, Ernst T, Senft CA
[Full Text]
Meeting Abstract (J-HSNC04)

The mechanical response of gliomas and peritumoral white matter under mechanical preconditioning

Tsitlakidis A, Kritis A, Tsingotjidou AS, Cheva A, Patsalas I, Foroglou N
[Full Text]
Meeting Abstract (P131)

Fractionated intracavitary radioimmunotherapy with Lu-177 labeled 6A10 Fab fragments in patients with glioblastoma – first patient experience

Müther M, Roll W, Böning G, Delker A, Warneke N, Gildehaus FJ, Schäfers M, Stegger L, Stummer W, Reulen HJ
[Full Text]
Meeting Abstract (P132)

An assessment of predictive factors for overall survival in glioblastoma – MGMT methylation is solely important for younger patients

Cosar T, Krigers A, Kerschbaumer J, Demetz M, Pinggera D, Freyschlag CF, Thomé C
[Full Text]
Meeting Abstract (P133)

Does positive MGMT methylation outbalance the limitation of subtotal resection in glioblastoma IDH-wildtype patients?

Müller M, Staub-Bartelt F, Ehrmann J, Hänggi D, Sabel M, Felsberg J, Rapp M
[Full Text]
Meeting Abstract (P134)

Longitudinal, multimodal, multicentre analysis of CNS-changes associated with resection of low-grade glioma – a feasibility study

Müller M, Kocher M, Radtke O, Elben S, Hänggi D, Sabel M, Rapp M
[Full Text]
Meeting Abstract (P135)

Metastatic markers as potential targets for the treatment of glioblastoma

Vogel M, Söhl B, Baumgarten P, Senft CA, Schwarz F, Freitag D
[Full Text]
Meeting Abstract (P136)

Resection of predominantly FLAIR-Hyperintense intracranial gliomas with minor contrast-enhancement – evaluation of tumour entities, extent of resection and outcome in a consecutive single-centre cohort

Kovacs E, Dao Trong HP, Jungk C, Scherer M, Unterberg AW
[Full Text]
Meeting Abstract (P137)

Augmented 5-aminolevulinic acid derived photodynamic therapy

Schwake M, Ott K, Schipmann S, Bunk E, Gorji A, Stummer W
[Full Text]
Meeting Abstract (P138)

Central neurocytoma – 30-day postoperative morbidity in a series of 30 patients

Atallah O, Al-Afif S, Samii A, Samii M, Sandalcioglu IE, Neyazi B, Krauss JK
[Full Text]